Apoptosis and expression of bcl-2 α, β mRNA isoforms and protein in neuroblastoma

Apoptosis

Volumn 1, Issue 1, 1996, Pages 63-68

  Mazzocco, K ^a   Scaruffi, P ^a   Gambini, C ^a   Negri, F ^a   Tonini, G P ^a,b  

^a G GASLINI INSTITUTE   (Italy)

^b Laboratory of Oncology   (Italy)

Author keywords

Apoptosis; Bcl 2; DNA fragmentation; Immuno histochemistry; Neuroblastoma; RT PCR

Indexed keywords

EID: 0012339123     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00142079     Document Type: Article

References (21)

1. De Bernardi B, Conte M, Mancini A, et al. Localized resectable neuroblastoma: results of the second study of Italian Cooperative Group for Neuroblastoma. J Clin Qncol 1995 ; 13: 884-893.
2. Haas D, Abiin AR, Miller C, et al. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 1988; 62: 818-825.
3. Pritchard J, Hickman JA. Why does stage 4s neuroblastoma regress spontaneously? Lancet 1994; 344: 869-870.
4. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: an historical perspective. In: Apoptosis: the molecular basis of cell death. Tomei LD and Coope FO, eds. New York: Cold Spring Harbor Laboratory, 1991: 5-29.
5. Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Cancer 1994; 73: 2013-2026.
6. Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Path 1995; 136: 593-608.
7. Hockenbery DM, Zutter M, Hickey W, et al. BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965.
8. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-442.
9. Garcia I, Martinou I, Tsujimoto Y, et al. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992; 258: 302-304.
10. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein in products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sei USA 1986; 83: 5214-5218.
11. Castle VP, Heidelberger KP, Bromberg J, et al. Expression of the apoptosis-suppressing protein BCL-2, in neuroblastoma is associated with unfavorable histology and N-MYC amplification. Am J Pathol 1993; 143: 1543-1450.
12. Weinreb M, Day PJR, Niggli F, et al. Bcl-2 oncoprotein in neuroblastoma. Lancet 1995; 345: 992-993.
13. Lasorella A, lavarone A, Israel MA. Differentiation of neuroblastoma enhances bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res 1995; 55: 4711-4716.
14. Tonini GP, Mazzocco K, Di Vinci A, Geido E, De Bernardi B, Giaretti W. Evidence of apoptosis in neuroblastoma at onset and relapse. An analysis of a large series of tumors. Neuro Oncology, in press.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
16. Munakata S, Hendricks JB. Effect of fixation time and microwave oven heating time on retrival of the Ki-67 antigen from paraffin-embedded tissue. J Histochem Cytochem 1993; 41: 1241-1246.
17. Hoehner JC, Hedborg F, Wiklund HJ, a al. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression. IntJ Cancer 1995; 62: 19-24.
18. Isaacs JT. Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer. Curr Opin Onc 1994; 6: 82-89.
19. Greenlund LJS, Korsmeyer SJ, Johnson EM. Role of bcl-2 in the survival and fuction of developing and mature sympathetic neurons. Neuron 1995; 15: 649-661.
20. Lahti JM, Valentine M, Xiang J, et al. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nature Genetics 1994;7: 370-375.
21. Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 1988; 6: 1874-1881.